Nivalis Therapeutics, Inc. (ALPN)
(Delayed Data from NSDQ)
$6.24 USD
-0.08 (-1.27%)
Updated May 3, 2019 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[ALPN]
Reports for Purchase
Showing records 141 - 156 ( 156 total )
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Q1 Financials; Recent Financing Supports Versatile Platform
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Q4 Financials; ?101 into the Clinic; Busy Year Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Q3 Financials; Lead Programs Prepare to Enter Clinic in 2019
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
CORRECTED: ASH 2018 Abstract Roundup and Schedule for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
ASH 2018 Abstract Roundup and Schedule for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Q2 Financials: Lead Asset On Track for Clinical Studies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Industry: Medical - Drugs
Initiating Coverage at OUTPERFORM; Supercharging the Immune Synapse
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R